PEDIATRICS
City of Hope is developing immune-based therapies for treating cancer, including neuroblastoma, one of the most common solid tumors of early childhood. An exciting area of research involves the development of adoptive T-cell therapy, a process by which T-cells (infection-fighting immune cells) are genetically engineered to produce a receptor that allows them to recognize and eliminate malignant tumor cells.